featured
Effect of Aflibercept Plus Modified FOLFOX6 Induction Chemotherapy Before Standard Chemoradiotherapy and Surgery in Patients With High-Risk Rectal Adenocarcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of Aflibercept Plus Modified FOLFOX6 Induction Chemotherapy Before Standard Chemoradiotherapy and Surgery in Patients With High-Risk Rectal Adenocarcinoma: The GEMCAD 1402 Randomized Clinical Trial
JAMA Oncol 2019 Aug 29;[EPub Ahead of Print], C Fernández-Martos, C Pericay, F Losa, R García-Carbonero, L Layos, N Rodríguez-Salas, M Martin-Richard, V Alonso-Orduña, R Vera, J Gallego, J Capdevila, A Salud, M Nogué, J Maurel, I Guash, C Montagut, C Lopez, I Macias, RK Jain, X Garcia-AlbenizFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.